Physician

Matthew F Fryzek, M.D.

According to 2025 Medicare claims, Matthew Fryzek, M.D. (NPI: 1417020595) practices internal medicine in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is BLUFFS FAMILY HEALTH CARE PC (NPI: 1194898296; TIN: 421291143) and primary practice location at 51503-4643. Fryzek is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), participating under the MSSP model.

Fryzek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 499 traditional Medicare patients, billed 5,380 HCPCS/CPT codes, and received $227,445 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 22,106 prescription claims across 762 beneficiaries totaling $2,095,374 in drug costs, led by Eliquis (Apixaban). DME data shows 912 claims. Open Payments data shows 139 records totaling $2,815. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $794,956 to $2,095,374. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $37,873 and ending at $50,150.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	407	3,673	$169,485
2016	730	6,564	$245,681
2017	693	6,451	$232,782
2018	710	7,328	$243,428
2019	683	6,734	$243,490
2020	810	7,960	$283,589
2021	809	8,689	$377,670
2022	693	6,534	$278,806
2023	553	5,409	$244,070
2024	499	5,380	$227,445

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	385	12,759	$794,956
2016	642	16,726	$1,033,860
2017	618	17,668	$1,137,057
2018	697	19,682	$1,384,416
2019	710	20,381	$1,442,648
2020	687	20,834	$1,509,622
2021	697	21,301	$1,779,979
2022	739	21,149	$1,895,461
2023	741	22,178	$2,176,716
2024	762	22,106	$2,095,374

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	65	641	$37,605
2016	94	717	$28,105
2017	93	644	$22,328
2018	199	897	$33,785
2019	221	911	$56,771
2020	257	1,015	$82,617
2021	239	1,062	$88,281
2022	219	916	$77,292
2023	275	1,120	$79,457
2024	214	912	$66,162

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	396	396	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	437	1,222	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	264	513	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	285	416	$12
36415	Insertion of needle into vein for collection of blood sample	445	1,232	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	308	12,706	$247,214
Ozempic	Semaglutide	127	4,592	$145,873
Farxiga	Dapagliflozin Propanediol	158	7,243	$136,188
Xarelto	Rivaroxaban	161	6,715	$124,255
Jardiance	Empagliflozin	156	6,124	$116,709

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	44	$33,374
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	34	$5,024
A7030	Full face mask used with positive airway pressure device, each	N	22	51	$3,816
A7031	Face mask interface, replacement for full face mask, each	N	21	51	$3,794
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	46	$3,154

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$2,815	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew F. Fryzek, M.D.?

Tedicare shows public-source Medicare data for Matthew F. Fryzek, M.D. (NPI 1417020595), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew F. Fryzek, M.D. have ACO affiliation data?

Matthew F. Fryzek, M.D. is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273).

What billing organization is linked to Matthew F. Fryzek, M.D.?

Matthew F. Fryzek, M.D. is linked to BLUFFS FAMILY HEALTH CARE PC (billing NPI 1194898296) in the available physician profile data.

Does Matthew F. Fryzek, M.D. have Open Payments data?

Matthew F. Fryzek, M.D. has 139 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.